Evidence map›Paper›PMID 40605411›Full record

ArticleTechnology in cancer research & treatment

Feasibility of Radiotherapy Fiducial Marker Tracking via Single-Shot X-ray Acoustic Tomography.

Norman Alexis Cantú-Delgado, Héctor Mauricio Garnica-Garza

Abstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Norman Alexis Cantú-DelgadoMonterrey Unit, Centro de Investigación y de Estudios Avanzados, Monterrey N.L., México.
Héctor Mauricio Garnica-GarzaMonterrey Unit, Centro de Investigación y de Estudios Avanzados, Monterrey N.L., México.ORCID 0000-0002-9800-4856

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introductionin radiotherapy, fiducial markers improve the accuracy of radiation delivery, and their use has become increasingly important in the treatment of various cancers, particularly those in the prostate and lung. This work aims to determine, via Monte Carlo simulations and numerical ultrasound transport, the feasibility of fiducial marker localization via single-shot x-ray acoustic computed tomography.Methodspatient data from CT scans for two treatment sites, prostate and lung, were used to model the fiducial marker localization process. Monte Carlo simulation was used to calculate the absorbed dose distribution in each patient resulting from the irradiation with a 120 kVp x-ray imaging source, assuming that the dose is imparted in a short pulse. Ultrasound transport through each patient was modeled with the numerical ultrasound transport package k-Wave. For the image reconstruction process, as the exact internal patient structure will not be known at the time of treatment, a homogenous medium with the patient external contour and dimensions was used.ResultsIt is shown that the use of a homogeneous model to approximate the actual patient material composition during the reconstruction process, necessary as the geometry of the internal structures is not known at the time of the treatment, severely degrades the quality of the x-ray acoustic tomography images, but that it is still possible to determine the fiducial marker position with an accuracy of or better than 1 mm. The largest errors are observed for the lung patient when the lung is in an inflated state.Conclusionsit has been shown that single-shot x-ray acoustic tomography can be an effective tool for the tracking and localization of radiotherapy fiducial markers, exhibiting an accuracy of better than 1 mm, despite the poor visual quality of the resultant images.

Indexed as

Fiducial MarkersLung NeoplasmsProstatic NeoplasmsRadiotherapy, Image-GuidedTomography, X-Ray ComputedFeasibility StudiesHumansMaleMonte Carlo MethodRadiotherapy DosageRadiotherapy Planning, Computer-Assistedacoustic tomographyfiducial markermonte carloradiotherapy

Identifiers

PMID40605411
PMCPMC12227932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.